C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes

Journal of Endocrinology

Volumn 194, Issue 2, 2007, Pages 275-281

  Yuan, Guoyue ^a,b   Chen, Xia ^a   Ma, Qinyun ^a   Qiao, Jie ^a   Li, Rongying ^a   Li, Xuesong ^a   Li, Shengxian ^c   Tang, Jinfeng ^a   Zhou, Libin ^a   Song, Huaidong ^a   Chen, Mingdao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JIANGSU UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADIPONECTIN; C REACTIVE PROTEIN; LUCIFERASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; ROSIGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; INSULIN SENSITIVITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SECRETION; SOUTHERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; C-REACTIVE PROTEIN; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; INFLAMMATION; MICE; MORPHOLINES; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TIME FACTORS; TRANSFECTION;

EID: 34547924074     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-07-0133     Document Type: Article

References (37)

1. Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ & Levy Y 2004 Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabetic Medicine 21 39-44.
2. Berg AH, Combs TP, Du X, Brownlee M & Scherer PE 2001 The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 7 947-953.
3. Berg AH, Combs TP & Scherer PE 2002 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism 13 84-89.
4. Bogan JS & Lodish HF 1999 Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP-30 and GLUT4. Journal of Cell Biology 146 609-620.
5. Burgering BM & Kops GJ 2002 Cell cycle and death control: long live Forkheads. Trends in Biochemical Sciences 27 352-360.
6. Chaldakov GN, Stankulov IS, Hristova M & Ghenev PI 2003 Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Current Pharmaceutical Design 9 1023-1031.
7. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB et al. 2002 Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143 998-1007.
8. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L et al. 2004 A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145 367-383.
9. Davis KE, Moldes M & Farmer SR 2004 The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. Journal of Biological Chemistry 279 4245-42461.
10. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R 2001 Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Letters 507 142-146.
11. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R 2002 Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 290 1084-1089.
12. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J & Paschke R 2003 Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 301 1045-1050.
13. Festa A, D'Agostino R, Jr, Tracy RP & Haffner SM 2002 Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51 1131-1137.
14. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ & Sattar N 2002 C-reactive protein is an independent predictor of risk for the development of diabetes in the west of scotland coronary prevention study. Diabetes 51 1596-1600.
15. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H & Koenig W 2000 Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23 1835-1839.
16. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE & Lodish HF 2001 Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. PNAS 98 2005-2010.
17. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K et al. 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 20 1595-1599.
18. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC & Matsuzawa Y 2001 Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50 1126-1133.
19. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H et al. 2002 Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 277 25863-25866.
20. Li RY, Song HD, Shi WJ, Hu SM, Yang YS, Tang JF, Chen MD & Chen JL 2004 Galanin inhibits leptin expression and secretion in rat adipose tissue and 3T3-L1 adipocytes. Journal of Molecular Endocrinology 33 11-19.
21. Libby P, Ridker PM & Maseri A 2002 Inflammation and atherosclerosis. Circulation 105 1135-1143.
22. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC & Krakoff J 2002 Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 57-58.
23. Lyon CJ, Law RE, Hsueh WA, Chaldakov GN, Stankulov IS, Hristova M & Ghenev PI 2003 Minireview: adiposity inflammation, and atherogenesis. Endocrinology 144 2195-2200.
24. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro, R, Ouchi N et al. 2001 PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 2094-2099.
25. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y et al. 2002 Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 8 731-737.
26. Marnell L, Mold C & Du Clos TW 2005 C-reactive protein: ligands, receptors and role in inflammation. Clinical Immunology 7 104-111.
27. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Nakamura T et al. 1999 Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 2473-2476.
28. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K et al. 2003 Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 671-674.
29. Ridker PM, Hennekens CH, Buring JE & Rifai N 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine 342 836-843.
30. Schulze MB, Rimm EB, Shai I, Rifai N & Hu FB 2004 Relationship between adiponectin and glycemic control, blood tipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 27 1680-1687.
31. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pradey RE & Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology Metabolism 86 1930-1935.
32. Xu A, Wong LC, Wang Y, Xu JY, Cooper GJ & Lam KS 2004 Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Letters 572 129-134.
33. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N et al. 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 7 941-946.
34. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K et al. 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 8 1288-1295.
35. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hoki K, Uchida S, Ito Y, Matsui J, Eto K et al. 2003 Globular adiponectin protected ob/ ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Journal of Biological Chemistry 24 2461-2468.
36. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y et al. 2000 Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 1723-1732.
37. Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F, Hong J, Gu Y, Li X, Ning G et al. 2006 Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Research and Clinical Practice 72 244-250.